Efficacy of the association of district specific and global rehabilitative techniques tailored for systemic sclerosis (SSc) patients

ISRCTN ISRCTN54093934
DOI https://doi.org/10.1186/ISRCTN54093934
Secondary identifying numbers N/A
Submission date
15/12/2008
Registration date
23/12/2008
Last edited
23/12/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Susanna Maddali Bongi
Scientific

Viale Pieraccini 18
Florence
50139
Italy

Study information

Study designRandomised controlled single centre trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Scientific titleThe rehabilitation of systemic sclerosis: efficacy of the association of district specific and global rehabilitative techniques - a randomised controlled trial
Study objectivesSystemic sclerosis (SSc) is a systemic disease affecting the microvascular system and the connective tissue, causing important alterations of skin and internal organs and impairing the function of the heart, lung, kidney and peripheral nervous system. In SSc, the most important rehabilitative problems arise from skin induration and joint and muscle involvement often insufficiently responsive to a merely pharmacological approach. In fact, involvement of skin with progressive tissue fibrosis and retraction is a major condition of disability.

This trial aims to assess the short- and mid-term efficacy of an individualised rehabilitation programme specifically conceived and tailored for SSc and to set the basis of a specific rehabilitative approach to this chronic disease.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSystemic sclerosis (SSc)
Intervention20 SSc patients were enrolled and randomly assigned to Group A or Group B:

Group A (10 patients) was treated for a 9-week period (twice a week, 1 hour per session) with an individualised rehabilitation program whose composition partially differed from patient to patient on the basis of involved districts and patient's expectations. All patients were treated with hand and face rehabilitation. Hand lymphatic drainage and global methods such as aquatic and land-based global rehabilitation, also comprising respiratory exercises, and Rességuier method were added when necessary.

Group B (10 patients) was the observational group, provided with education advices and medical information about SSc.
Intervention typeOther
Primary outcome measureImprovement in disability and quality of life, assessed by the 36-item Short Form (SF-36) Health Survey and the Health Assessment Questionnaire (HAQ).
Secondary outcome measuresHand and face involvement:
1. Hand Mobility in Scleroderma (HAMIS) test
2. Cochin Functional Hand Scale
3. Water Volumetric Test
4. Mouth functionality
5. Hand range of motion
Overall study start date01/04/2007
Completion date20/04/2008

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants20
Key inclusion criteria1. Diagnosis of systemic sclerosis according to the American College of Rheumatology (ACR) criteria
2. Facial skin score greater than 1
3. SSc hand involvement
4. No age limits
Key exclusion criteriaDoes not meet the inclusion criteria
Date of first enrolment01/04/2007
Date of final enrolment20/04/2008

Locations

Countries of recruitment

  • Italy

Study participating centre

Viale Pieraccini 18
Florence
50139
Italy

Sponsor information

Italian Association for the Study of Systemic Sclerosis and Fibrotic Diseases (ASSMaF) (Italy)
Research organisation

Viale Pieraccini 18
Florence
50139
Italy

Website http://www.assmaf.org
ROR logo "ROR" https://ror.org/00feyy410

Funders

Funder type

Research organisation

Italian Association for the Study of Systemic Sclerosis and Fibrotic Diseases (ASSMaF) (Italy)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan